NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504 | -13.0% | 41,000 | +13.9% | 0.36% | -4.6% |
| Q2 2023 | $579 | +66.4% | 36,000 | +80.0% | 0.37% | +65.3% |
| Q1 2023 | $348 | -100.0% | 20,000 | -28.6% | 0.22% | -44.7% |
| Q4 2021 | $955,000 | -29.3% | 28,000 | 0.0% | 0.41% | -28.7% |
| Q3 2021 | $1,351,000 | +19.7% | 28,000 | +12.0% | 0.57% | +17.0% |
| Q2 2021 | $1,129,000 | -19.5% | 25,000 | -34.2% | 0.49% | -29.1% |
| Q3 2020 | $1,402,000 | +19.1% | 38,000 | 0.0% | 0.69% | +8.9% |
| Q2 2020 | $1,177,000 | +29.2% | 38,000 | +15.2% | 0.63% | -7.1% |
| Q1 2020 | $911,000 | – | 33,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |